SILO Silo Pharma rises 557 percent despite reporting a wider than expected Q4 2023 per share loss NAMI Jinxin management outlines targeted AI service investments to support next phase of operational growth Korea KEP Growth Trajectory Korea posts 10 EPS miss amid cost pressures Linde plc LIN Bullish Analyst Backing Reinforces Dividend Aristocrat Investment Case for 2026 EPC El Paso leadership outlines core strategic priorities to drive future revenue growth in latest quarterly earnings call